Background/Objectives: Sarcopenia and cognitive decline (CD) are prevalent in aging populations, impacting functionality and quality of life. The early detection of these diseases is challenging, often relying on in-person screening, which is difficult to implement regularly. This study aims to develop artificial intelligence algorithms based on gait analysis, integrating sensor and computer vision (CV) data, to detect sarcopenia and CD. Methods: A cross-sectional case-control study was conducted involving 42 individuals aged 60 years or older. Participants were classified as having sarcopenia if they met the criteria established by the European Working Group on Sarcopenia in Older People and as having CD if their score in the Mini-Mental State Examination was ≤24 points. Gait patterns were assessed at usual walking speeds using sensors attached to the feet and lumbar region, and CV data were captured using a camera. Several key variables related to gait dynamics were extracted. Finally, machine learning models were developed using these variables to predict sarcopenia and CD. Results: Models based on sensor data, CV data, and a combination of both technologies achieved high predictive accuracy, particularly for CD. The best model for CD achieved an F1-score of 0.914, with a 95% sensitivity and 92% specificity. The combined technologies model for sarcopenia also demonstrated high performance, yielding an F1-score of 0.748 with a 100% sensitivity and 83% specificity. Conclusions: The study demonstrates that gait analysis through sensor and CV fusion can effectively screen for sarcopenia and CD. The multimodal approach enhances model accuracy, potentially supporting early disease detection and intervention in home settings.

Background/Objectives: Cognitive impairment in older adults is a growing public health concern due to global population aging. Early detection is crucial, yet current screening methods are time-consuming and require clinical expertise. Gait analysis has emerged as a promising alternative for cognitive screening. The aim of the study was to identify gait variables associated with cognitive impairment and to develop predictive algorithms capable of distinguishing between cognitively impaired and non-impaired older adults using gold-standard gait analysis. Methods: A cross-sectional study was conducted with 42 adults aged > 60 years. Cognitive function was assessed using the Mini-Mental State Examination (MMSE), and participants were divided into high (MMSE > 24) and low (MMSE ≤ 24) cognitive function groups. Spatiotemporal gait parameters were recorded at participants’ usual pace using the Optogait system. Logistic regression models were developed using half of the sample (training group) and validated in the remaining participants (verification group). Results: Algorithms based on stride length and double support time demonstrated high classification performance. In the training group, the best-performing model achieved an AUC-ROC of 0.91, with a sensitivity of 71.4% and specificity of 92.3%. Validation in the verification group yielded an AUC-ROC of 0.84 and accuracy of 81.0%. Alternative models showed acceptable to excellent predictive power. Conclusions: Gait analysis using gold-standard methods can effectively identify cognitive impairment in older adults. The developed algorithms offer a rapid, objective, and accurate screening alternative with strong potential for clinical application.